Literature DB >> 22266146

Fixed drug eruption due to norfloxacin and cross-reactivity with other quinolones.

L Sánchez-Morillas1, P Rojas Pérez-Ezquerra2, M L González Morales3, C Mayorga4, R González-Mendiola2, J J Laguna Martínez2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22266146     DOI： 10.1016/j.aller.2011.10.004

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN： 0301-0546            Impact factor:   1.667


× No keyword cloud information.
  5 in total

Review 1.  Update on Quinolone Allergy.

Authors:  Inmaculada Doña; Esther Moreno; Natalia Pérez-Sánchez; Inmaculada Andreu; Dolores Hernández Fernandez de Rojas; María José Torres
Journal:  Curr Allergy Asthma Rep       Date:  2017-08       Impact factor: 4.806

2.  Ciprofloxacin-induced generalised non-bullous fixed drug eruption.

Authors:  Mohamed Iliyas; Mudda Ram Subba Reddy; Uma Devi
Journal:  BMJ Case Rep       Date:  2018-06-04

3.  Immediate Hypersensitivity to Fluoroquinolones: 
A Cohort Assessing Cross-Reactivity.

Authors:  Sara F Azimi; Vincent Mainella; Meghan N Jeffres
Journal:  Open Forum Infect Dis       Date:  2022-03-02       Impact factor: 3.835

4.  Fixed drug eruptions caused by cross-reactive quinolones.

Authors:  P Deepa Kameswari; Nitya Selvaraj; Mangaiarkkarasi Adhimoolam
Journal:  J Basic Clin Pharm       Date:  2014-03

5.  Cefotaxime induced generalized bullous fixed drug eruption - A case report.

Authors:  R Manikandan; A Porselvi; G C Keerthana; K Vaishnavi; S Girija; Murali Narasimhan; T M Vijayakumar
Journal:  Toxicol Rep       Date:  2018-10-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.